Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2006 (2006), Article ID 39508, 8 pages
Review Article

Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment

1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA
2Departament de Fisiologia, Facultat de Farmacia, Universitat de Barcelona, Barcelona 08028, Spain
3School of Medicine, University of Wisconsin and William S. Middleton Memorial Veterans Administration, Madison, WI 53705, USA
4Voyager Pharmaceutical Corporation, Raleigh, NC 27615, USA

Received 5 January 2006; Revised 10 May 2006; Accepted 28 June 2006

Copyright © 2006 Gemma Casadesus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Anil Kumar, and Samrita Dogra, “Neuropathology and therapeutic management of Alzheimer's disease - an update,” Drugs Of The Future, vol. 33, no. 5, pp. 433–446, 2008. View at Publisher · View at Google Scholar
  • Emma Ramiro-Puig, Gemma Casadesús, Hyoung-gon Lee, Xiongwei Zhu, Andrew McShea, George Perry, Francisco J. Pérez-Cano, Mark A. Smith, and Margarida Castell, “Neuroprotective effect of cocoa flavonids on in vitro oxidative stress,” European Journal of Nutrition, vol. 48, no. 1, pp. 54–61, 2008. View at Publisher · View at Google Scholar
  • Vladan P. Bajic, Biljana Spremo-Potparevic, Lada Živkovic, David J. Bonda, Sandra L. Siedlak, Gemma Casadesus, Hyoung-gon Lee, and Mark A. Smith, “The X-chromosome instability phenotype in Alzheimer’s disease: A clinical sign of accelerating aging?,” Medical Hypotheses, vol. 73, no. 6, pp. 917–920, 2009. View at Publisher · View at Google Scholar
  • Adnan Erol, “Are Paradoxical Cell Cycle Activities in Neurons and Glia Related to the Metabolic Theory of Alzheimer's Disease?,” Journal Of Alzheimers Disease, vol. 19, no. 1, pp. 129–135, 2010. View at Publisher · View at Google Scholar
  • Joseph Prandota, “Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis,” Research in Autism Spectrum Disorders, vol. 5, no. 1, pp. 14–59, 2011. View at Publisher · View at Google Scholar
  • Emily R. Rosario, Jenna C. Carroll, and Christian J. Pike, “Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice,” Brain Research, vol. 1466, pp. 137–145, 2012. View at Publisher · View at Google Scholar
  • Tomihisa Niitsu, Hideki Okamoto, and Masaomi Iyo, “Behavioural and psychological symptoms of dementia in an Alzheimer's disease case successfully treated with natural medicine: association with gonadotropins,” Psychogeriatrics, vol. 13, no. 2, pp. 124–127, 2013. View at Publisher · View at Google Scholar
  • Sevki Cetinkalp, Sibel Ertek, and Ilgin Y. Simsir, “Insulin resistance in brain and possible therapeutic approaches,” Current Vascular Pharmacology, vol. 12, no. 4, pp. 553–564, 2014. View at Publisher · View at Google Scholar
  • Vladan Bajic, Biljana Spremo-Potparevic, Lada Zivkovic, Esma R. Isenovic, and Thomas Arendt, “Cohesion and the aneuploid phenotype in Alzheimer's disease: a tale of genome instability,” Neuroscience & Biobehavioral Reviews, 2015. View at Publisher · View at Google Scholar
  • Vladan Bajic, Vesna Mandusic, Elka Stefanova, Ana Bozovic, Radoslav Davidovic, Lada Zivkovic, Andrea Cabarkapa, and Biljana Spremo-Potparevic, “Skewed X-Chromosome Inactivation in Women Affected by Alzheimer's Disease,” Journal Of Alzheimers Disease, vol. 43, no. 4, pp. 1251–1259, 2015. View at Publisher · View at Google Scholar